Cannassure Therapeutics Ltd Share Price
Equities
CSURE-M
IL0001110134
Healthcare Facilities & Services
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,326 ILa | +10.04% | +18.39% | +174.53% |
Sales 2022 | 33.78 12.86K 2.7K | Sales 2023 | 11 4.19K 880.42 | Capitalization | 4M 1.52B 320M |
---|---|---|---|---|---|
Net income 2022 | -5M -1.9B -400M | Net income 2023 | -1M -381M -80.05M | EV / Sales 2022 | 1,023,292 x |
Net Debt 2022 | 29.96M 11.41B 2.4B | Net Debt 2023 | 434K 165M 34.74M | EV / Sales 2023 | 403,186 x |
P/E ratio 2022 |
-0.84
x | P/E ratio 2023 |
-2.24
x | Employees | 72 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 81.66% |
1 day | +10.04% | ||
1 week | +18.39% | ||
Current month | +14.31% | ||
1 month | +30.38% | ||
3 months | +142.41% | ||
6 months | +228.22% | ||
Current year | +174.53% |
Managers | Title | Age | Since |
---|---|---|---|
Ada Bar Kama
CEO | Chief Executive Officer | 54 | 30/03/22 |
Nir Peles
CHM | Chairman | 50 | 03/12/18 |
Daniel Spira
AUD | Comptroller/Controller/Auditor | 69 | 25/06/19 |
Members of the board | Title | Age | Since |
---|---|---|---|
Shimon Bar-Kama
BRD | Director/Board Member | 71 | 03/12/18 |
Nir Peles
CHM | Chairman | 50 | 03/12/18 |
Varda Kalal
BRD | Director/Board Member | 56 | 13/02/22 |
Date | Price | Change | Volume |
---|---|---|---|
25/04/24 | 1,326 | +10.04% | 9,810 |
24/04/24 | 1,205 | 0.00% | 1,344 |
21/04/24 | 1,205 | +7.59% | 2,648 |
18/04/24 | 1,120 | +2.85% | 1,990 |
Delayed Quote TEL AVIV STOCK EXCHANGE, April 25, 2024 at 12:24 pm
More quotes1st Jan change | Capi. | |
---|---|---|
+174.53% | 7.76M | |
+31.96% | 272M | |
+33.74% | 261M | |
+49.42% | 194M | |
+44.98% | 131M | |
-42.17% | 119M | |
-28.57% | 121M | |
+115.91% | 119M | |
0.00% | 86.82M | |
+150.00% | 75.33M |
- Stock Market
- Equities
- CSURE-M Stock